Good evening :)
Place Order
Add to Watchlist

Gujarat Terce Laboratories Ltd

GUJTERC

Gujarat Terce Laboratories Ltd

GUJTERC
Health CarePharmaceuticals
SmallcapWith a market cap of ₹23 cr, stock is ranked 3,624
High RiskStock is 6.88x as volatile as Nifty
33.924.98% (+1.61)
33.924.98% (+1.61)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹23 cr, stock is ranked 3,624
High RiskStock is 6.88x as volatile as Nifty
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹23 cr, stock is ranked 3,624
High RiskStock is 6.88x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
47.953.49
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
52.225.980.56%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Gujarat Terce Laboratories is engaged in manufacturing of tablets, capsules, and syrup and injection pertaining to the product group pharmaceuticals.

Investor Presentation

View older 

Feb 5, 2024

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 9.88%, vs industry avg of 8.36%

Constant Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share stayed at 0.01%

Loading...

Financial YearFY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023TTM
Total Revenue26.5625.1925.7329.4231.3537.8325.9840.4447.1348.99
Raw Materialssubtract9.969.919.3711.0311.8414.2810.2517.8817.7048.58
Power & Fuel Costsubtract0.050.050.050.060.080.100.100.160.11
Employee Costsubtract8.7110.3810.6411.9312.8214.8112.6315.4920.24
Selling & Administrative Expensessubtract5.023.493.573.823.856.023.935.977.70
Operating & Other expensessubtract1.971.001.581.851.961.661.03-0.483.19
Depreciation/Amortizationsubtract0.160.190.190.190.210.240.180.280.360.43
Interest & Other Itemssubtract0.410.380.310.230.250.290.390.400.720.70
Taxes & Other Itemssubtract0.210.460.030.05-0.090.16-0.01-0.13-1.22-1.22
EPS0.09-0.90-0.010.350.580.36-3.401.17-2.250.67
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2022

Annual report

PDF

Investor Presentation

Oct 28PDF
FY 2023

Annual report

PDF

Investor Presentation

May 13PDF
May 13PDF
FY 2024

Annual Report Pending

Investor Presentation

Feb 5PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Gujarat Terce Laboratories Ltd-14.363.49
Sun Pharmaceutical Industries Ltd44.096.300.74%
Cipla Ltd42.355.000.58%
Dr Reddy's Laboratories Ltd23.794.610.62%

Price Comparison

Compare GUJTERC with any stock or ETF
Compare GUJTERC with any stock or ETF
GUJTERC
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding37.01%0.00%0.00%0.00%62.99%

Mar 2023

Jun 2023

Sep 2023

Dec 2023

Shareholding History

SepDec '22MarJunSepDec '230.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

GUJTERC has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time